Mariner’s TuHURA Biosciences HURA Stock Holding History

Mariner’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.7K	Sell	22,109 -3,588	-14%	-$8.36K	﹤0.01%	3408
2026 Q1	$46K	Buy	+25,697	New	+$31.5K	﹤0.01%	3433
2022 Q4	–	Sell	-10	Closed	-$2K	–	2855
2022 Q3	$2K	Buy	+10	New	+$3.2K	﹤0.01%	2439

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner's HURA Position: Q2 2026 in Review

Mariner reduced its TuHURA Biosciences (HURA) stake by 14% in Q2 2026, selling an estimated $8.36K and leaving 22,109 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Mariner first reported a position in HURA in Q3 2022 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Mariner held 22,109 shares of TuHURA Biosciences worth $51.7K as of Q2 2026.
Mariner sold 3,588 TuHURA Biosciences shares in Q2 2026, an estimated $8.36K.
TuHURA Biosciences made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3408 holding.
Mariner first reported a position in TuHURA Biosciences in Q3 2022 and has held it in 3 quarters since.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.